Inventor of 4-disease drug hears from investors, readers | ISRAEL21c

Inventor of 4-disease drug hears from investors, readers | ISRAEL21c

#MedicalUpdate

Inventor of 4-disease drug hears from investors, readers

ISRAEL21c article on David Naor’s peptide drew a $5k investment and many reader inquiries. An Israeli biotech company is planning clinical studies.

By Abigail Klein Leichman  JULY 11, 2019, 8:20 AM

Abigail Klein Leichman

Abigail Klein Leichman is a writer and associate editor at ISRAEL21c. Prior to moving to Israel in 2007, she was a specialty writer and copy editor at a major daily newspaper in New Jersey and has freelanced for a variety of newspapers and periodicals since 1984.